BMED ETF Price & Analysis
BMED ETF Chart & Stats
$28.66
--
Market closed
$28.66
--
Day’s Range― - ―
52-Week Range$20.57 - $32.19
Previous Close$28.66
VolumeN/A
Average Volume (3M)5.28K
AUM10.21M
NAV28.78
Expense Ratio0.55%
Holdings Count45
Beta0.74
Inception DateSep 29, 2020
Last Dividend Ex-Date
Dec 20, 2023Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume1,868
30 Day Avg. Volume5,280
AlphaN/A
ETF Overview
Future Health ETF
The Future Health ETF (Ticker: BMED) offers investors a unique opportunity to gain targeted exposure to the burgeoning health care sector. As a sector-focused exchange-traded fund, BMED zeroes in on a broad-based niche within health care, capturing the dynamic and rapidly evolving landscape of medical innovation and technological advancement. This ETF is designed for forward-thinking investors aiming to capitalize on the transformative trends reshaping health care, including biotechnology advancements, cutting-edge medical devices, and revolutionary health care services.
By investing in BMED, shareholders are positioned to benefit from a diversified portfolio of companies at the forefront of future health developments. This ETF is ideal for those looking to align their investment strategy with the promising prospects of health care innovation, making it a compelling choice for anyone eager to participate in the next wave of health care evolution. With a focus on both established leaders and emerging pioneers in the industry, the Future Health ETF provides a balanced approach to investing in the health care sector's future potential.
Future Health ETF (BMED) Fund Flow Chart
Future Health ETF (BMED) 1 year Net Flows: $7M
BMED ETF News
BMED ETF FAQ
What was BMED’s price range in the past 12 months?
BMED lowest ETF price was $20.57 and its highest was $32.19 in the past 12 months.
What is the AUM of BMED?
As of Mar 25, 2026 The AUM of BMED is 10.21M.
Is BMED overvalued?
According to Wall Street analysts BMED’s price is currently Undervalued.
Does BMED pay dividends?
BMED pays a Notavailable dividend of $0.007 which represents an annual dividend yield of N/A. See more information on BMED dividends here
How many shares outstanding does BMED have?
Currently, no data Available
Which hedge fund is a major shareholder of BMED?
Currently, no hedge funds are holding shares in BMED
BMED ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Johnson & Johnson
7.85%
U.S. Dollar
6.82%
Merck & Company
4.64%
Amgen Inc
4.52%
Edwards Lifesciences Corp.
4.51%
McKesson Corporation
4.28%
Gilead Sciences
3.93%
Wuxi Biologics (Cayman)
3.09%
Biogen Inc.
3.05%
Waters Corp
3.01%
Total45.71%
See All Holdings


